Estrogen and androgen blockade for advanced prostate cancer in the era of precision medicine

T Fujimura, K Takayama, S Takahashi… - The Road from …, 2019 - taylorfrancis.com
Prostate cancer (PC) is the second-most frequently diagnosed cancer in men worldwide,
with 1.1 million new cases estimated to have occurred in 2012. Chemoprevention, prostate …
被引用次数：33 相关文章
[PDF] scienceopen.com

[PDF][PDF] Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - scienceopen.com
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - search.proquest.com
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - pubmed.ncbi.nlm.nih.gov
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

[引用][C] Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers (Web), 2018 - jglobal.jst.go.jp
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision
Medicine | Article Information | J-GLOBAL Art J-GLOBAL ID:201902234112643241 …

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - search.ebscohost.com
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

[引用][C] Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - cir.nii.ac.jp
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision
Medicine | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML] nih.gov

[HTML][HTML] Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - ncbi.nlm.nih.gov
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.

T Fujimura, K Takayama, S Takahashi, S Inoue - Cancers, 2018 - europepmc.org
Androgen deprivation therapy (ADT) has been widely prescribed for patients with advanced
prostate cancer (PC) to control key signaling pathways via androgen receptor (AR) and AR …

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine

T Fujimura, K Takayama, S Takahashi… - The Road from …, 2020 - taylorfrancis.com
Prostate cancer (PC) is the second-most frequently diagnosed cancer in men worldwide,
with 1.1 million new cases estimated to have occurred in 2012. Systematic treatment for …